These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22911764)

  • 1. Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors.
    Lerret NM; Rogozinska M; Jaramillo A; Marzo AL
    PLoS One; 2012; 7(7):e41240. PubMed ID: 22911764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and preliminary evidence of biologic efficacy of a mammaglobin-a DNA vaccine in patients with stable metastatic breast cancer.
    Tiriveedhi V; Tucker N; Herndon J; Li L; Sturmoski M; Ellis M; Ma C; Naughton M; Lockhart AC; Gao F; Fleming T; Goedegebuure P; Mohanakumar T; Gillanders WE
    Clin Cancer Res; 2014 Dec; 20(23):5964-75. PubMed ID: 25451106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
    Narayanan K; Jaramillo A; Benshoff ND; Campbell LG; Fleming TP; Dietz JR; Mohanakumar T
    J Natl Cancer Inst; 2004 Sep; 96(18):1388-96. PubMed ID: 15367572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers.
    Bharat A; Benshoff N; Fleming TP; Dietz JR; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2008 Aug; 110(3):453-63. PubMed ID: 17874294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes.
    Soysal SD; Muenst S; Kan-Mitchell J; Huarte E; Zhang X; Wilkinson-Ryan I; Fleming T; Tiriveedhi V; Mohanakumar T; Li L; Herndon J; Oertli D; Goedegebuure SP; Gillanders WE
    Breast Cancer Res Treat; 2014 Oct; 147(3):527-37. PubMed ID: 25212176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale.
    Wang X; Naranjo A; Brown CE; Bautista C; Wong CW; Chang WC; Aguilar B; Ostberg JR; Riddell SR; Forman SJ; Jensen MC
    J Immunother; 2012; 35(9):689-701. PubMed ID: 23090078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of CD8+ cytotoxic T lymphocytes against breast cancer cells by stimulation with mammaglobin-A-pulsed dendritic cells.
    Manna PP; Jaramillo A; Majumder K; Campbell LG; Fleming TP; Dietz JR; Dipersio JF; Mohanakumar T
    Breast Cancer Res Treat; 2003 May; 79(1):133-6. PubMed ID: 12779090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant mammaglobin A adenovirus-infected dendritic cells induce mammaglobin A-specific CD8+ cytotoxic T lymphocytes against breast cancer cells in vitro.
    Cui H; Zhang W; Hu W; Liu K; Wang T; Ma N; Liu X; Liu Y; Jiang Y
    PLoS One; 2013; 8(5):e63055. PubMed ID: 23650543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T
    Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope-specific regulation of memory programming by differential duration of antigen presentation to influenza-specific CD8(+) T cells.
    Ballesteros-Tato A; León B; Lee BO; Lund FE; Randall TD
    Immunity; 2014 Jul; 41(1):127-40. PubMed ID: 25035957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.
    Tiriveedhi V; Sarma NJ; Subramanian V; Fleming TP; Gillanders WE; Mohanakumar T
    Hum Immunol; 2012 Jan; 73(1):11-6. PubMed ID: 22074997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
    Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
    J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunodominant HLA-B7-restricted CD8+ cytotoxic T cell epitopes derived from mammaglobin-A expressed on human breast cancers.
    Ilias Basha H; Tiriveedhi V; Fleming TP; Gillanders WE; Mohanakumar T
    Breast Cancer Res Treat; 2011 May; 127(1):81-9. PubMed ID: 20544273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent immunotherapy against well-established thymoma using adoptively transferred transgene IL-6-engineered dendritic cell-stimulated CD8+ T-cells with prolonged survival and enhanced cytotoxicity.
    Kalyanasundaram Bhanumathy K; Zhang B; Xie Y; Xu A; Tan X; Xiang J
    J Gene Med; 2015; 17(8-9):153-60. PubMed ID: 26212685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.
    Viehl CT; Tanaka Y; Chen T; Frey DM; Tran A; Fleming TP; Eberlein TJ; Goedegebuure PS
    Breast Cancer Res Treat; 2005 Jun; 91(3):271-8. PubMed ID: 15952060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour.
    Song S; Zhang K; You H; Wang J; Wang Z; Yan C; Liu F
    Clin Exp Immunol; 2010 Oct; 162(1):75-83. PubMed ID: 20735440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotype and Hierarchy of Two Transgenic T Cell Lines Targeting the Respiratory Syncytial Virus KdM282-90 Epitope Is Transfer Dose-Dependent.
    Morabito KM; Erez N; Graham BS; Ruckwardt TJ
    PLoS One; 2016; 11(1):e0146781. PubMed ID: 26752171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
    Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
    J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive T-cell transfer combined with a single low dose of total body irradiation eradicates breast tumors.
    Lerret NM; Marzo AL
    Oncoimmunology; 2013 Feb; 2(2):e22731. PubMed ID: 23525138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.
    Rubinstein MP; Kadima AN; Salem ML; Nguyen CL; Gillanders WE; Cole DJ
    J Immunol; 2002 Nov; 169(9):4928-35. PubMed ID: 12391205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.